Cigna Group

Listed Company

CICIK 0001739940NYSELarge AcceleratedHospital & Medical Service PlansDelawareFY ends Dec 31

Period

FY 2025

Revenue

$274.90B

Net Income

$5.96B

Total Assets

$157.92B

Equity

$41.71B

Shares Out

264.53M

Op. Cash Flow

$9.60B

Business

Cigna Group is a global health company that delivers integrated medical, pharmacy and care services to individuals, employers, government programs and other clients. It offers pharmacy benefit management, home delivery and specialty pharmacy, care delivery and care management programs, administrative and insured medical plans, behavioral and dental solutions, and other health-related services. The company reports two primary platforms—Evernorth Health Services (Pharmacy Benefit Services; Specialty and Care Services) and Cigna Healthcare (U.S. Healthcare; International Health)—along with Other Operations and corporate functions. It operates across the United States and in more than 30 countries, distributing products through brokers, direct sales, private and public exchanges, and partnerships with providers and government programs.

Summary from filing dated 2025-02-27

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Premiums	40,261	45,996	44,237	39,916	41,154
Net investment income	1,046	973	1,166	1,155	1,549
TOTAL REVENUES	274,900	247,121	195,265	180,518	174,069
Pharmacy and other service costs	214,991	182,509	133,801	124,834	117,553
Medical costs and other benefit expenses	34,349	38,648	36,287	32,184	33,565
Selling, general and administrative expenses	14,617	14,844	14,822	13,174	13,012
Amortization of acquired intangible assets	1,743	1,703	1,819	1,876	1,998
TOTAL BENEFITS AND EXPENSES	265,700	237,704	186,729	172,068	166,128
Income from operations	9,200	9,417	8,536	8,450	7,941
Interest expense and other	−1,408	−1,435	−1,446	−1,228	−1,208
Net gain (loss) on sale of businesses	13	24	−1,499	1,662	0
Net investment losses	−24	−2,737	−78	−487	—
Income before income taxes	7,781	5,269	5,513	8,397	6,790
TOTAL INCOME TAXES	1,493	1,491	141	1,615	1,370
Net income	6,288	3,778	5,372	6,782	5,420
Less: Net income attributable to noncontrolling interests	331	344	208	78	50
SHAREHOLDERS' NET INCOME	5,957	3,434	5,164	—	—
Basic (in dollars per share)	22.33	12.25	17.57	21.66	15.89
Diluted (in dollars per share)	22.18	12.12	17.39	21.41	15.75

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	7,676	7,550	7,822	5,924	5,081
Investments	1,056	665	925	905	920
Accounts receivable, net	28,768	24,227	17,722	17,218	15,071
Inventories	7,338	6,692	5,645	4,777	3,722
Other current assets	2,976	2,732	2,169	1,298	1,283
Assets of businesses held for sale	0	7,004	3,068	0	10,057
Total current assets	47,814	48,870	37,351	30,122	36,134
Long-term investments	18,471	15,128	17,985	16,288	18,438
Reinsurance recoverables	4,103	4,378	4,835	5,416	4,970
Property and equipment	3,651	3,654	3,695	3,774	3,692
Goodwill	44,924	44,370	44,259	45,811	45,811
Other intangible assets	28,560	29,417	30,863	32,492	34,102
Other assets	2,885	2,786	3,421	2,704	3,405
Separate account assets	7,511	7,278	—	—	—
TOTAL ASSETS	157,919	155,881	152,761	143,885	154,889
Current insurance and contractholder liabilities	5,710	5,388	5,514	5,409	5,318
Pharmacy and other service costs payable	30,333	28,465	19,815	17,070	15,309
Accounts payable	10,659	9,294	8,553	7,775	6,655
Accrued expenses and other liabilities	9,048	9,387	9,955	7,978	7,322
Short-term debt	592	3,035	2,775	2,993	2,545
Liabilities of businesses held for sale	0	2,410	2,104	0	6,423
Total current liabilities	56,342	57,979	48,716	41,225	43,572
Non-current insurance and contractholder liabilities	9,938	10,254	10,904	11,976	12,563
Deferred tax liabilities, net	7,145	6,975	7,173	7,786	8,346
Other non-current liabilities	4,238	3,215	3,441	2,766	3,762
Long-term debt	30,871	28,937	28,155	28,100	31,125
Separate account liabilities	7,511	7,278	7,430	7,278	8,337
TOTAL LIABILITIES	116,045	114,638	106,410	99,131	107,705
Contingencies Note 22	—	—	—	—	—
Common stock	4	4	4	4	4
Additional paid-in capital	31,790	31,288	30,669	30,233	29,574
Accumulated other comprehensive loss	−2,806	−2,341	−1,864	−1,658	−884
Retained earnings	47,865	43,519	41,652	37,940	32,593
Less: Treasury stock, at cost	−35,140	−31,437	−24,238	−21,844	−14,175
TOTAL SHAREHOLDERS' EQUITY	41,713	41,033	46,223	44,675	47,112
Noncontrolling interests	161	210	21	13	18
Total equity	41,874	41,243	46,244	44,688	46,976
Total liabilities and equity	157,919	155,881	152,761	143,885	154,889

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	2,775	2,775	3,035	2,937	2,923
Deferred income tax expense (benefit)	326	−95	−1,659	−472	−216
Accounts receivable, net	−4,630	−7,369	−1,663	−2,237	−2,843
Inventories	−646	−1,032	−868	−1,055	−557
Reinsurance recoverable and Other assets	−897	−485	−539	393	−655
Insurance liabilities	1,247	−591	584	−336	805
Pharmacy and other service costs payable	1,868	8,757	2,030	1,760	1,961
Accounts payable and Accrued expenses and other liabilities	2,797	1,138	3,481	1,734	77
Other, net	462	774	463	325	333
NET CASH PROVIDED BY OPERATING ACTIVITIES	9,601	10,363	11,813	8,656	7,191
Debt securities and equity securities	782	856	1,078	1,744	2,030
Debt securities and equity securities	986	839	972	1,327	1,628
Commercial mortgage loans	223	188	186	98	180
Other sales, maturities and repayments (primarily short-term and other long-term investments)	884	752	586	1,039	1,936
Debt securities and equity securities	−5,788	−1,386	−4,334	−2,756	−3,553
Commercial mortgage loans	−117	−54	−118	−161	−327
Other (primarily short-term and other long-term investments)	−1,416	−1,309	−1,205	−1,563	−2,554
Property and equipment purchases, net	−1,212	−1,406	−1,573	−1,295	−1,154
Acquisitions, net of cash acquired	−597	−131	−447	0	−1,833
Divestitures, net of cash sold	2,984	521	13	4,835	−61
Renewable energy tax credit equity investments	−1,102	−1,030	−313	−125	—
Other, net	−34	58	−19	−45	97
NET CASH USED IN INVESTING ACTIVITIES	−4,407	−2,102	−5,174	3,098	−3,611
Deposits and interest credited to contractholder deposit funds	152	166	167	164	153
Withdrawals and benefit payments from contractholder deposit funds	−253	−228	−223	−220	−168
Net change in short-term debt, excluding term loan	−927	−402	1,198	−2,059	975
Net proceeds on issuance of term loan	1,999	0	0	0	0
Repayment of term loan	−2,000	0	0	0	0
Repayment of long-term debt	−4,197	−3,000	−2,967	−500	−4,578
Net proceeds on issuance of long-term debt	4,458	4,462	1,491	0	4,260
Repurchase of common stock	−3,621	−7,034	−2,284	−7,607	−7,742
Issuance of common stock	203	305	187	389	326
Common stock dividend paid	−1,611	−1,567	−1,450	−1,384	−1,341
Other, net	−624	−349	−413	−23	39
NET CASH USED IN FINANCING ACTIVITIES	−6,421	−7,647	−4,294	−11,240	−8,212
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash	32	−20	16	−86	−65
Net (decrease) increase in cash, cash equivalents and restricted cash	−1,195	594	2,361	428	−4,697
Interest paid	1,350	1,342	1,330	1,229	1,253

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro